Hi everyone,
I wanted to send a quick update regarding some news many of you may have seen circulating, Peptide Sciences has recently shut down.
At this point, it does not appear to be a regulatory shutdown, but it does highlight something I’ve talked about with many of you before: the research peptide space continues to be volatile and constantly shifting.
This industry operates in a gray zone, and companies are navigating changing pressures from multiple directions, not just regulatory oversight, but also things like payment processing, banking relationships, and platform restrictions. As many of you know, credit card processing has been one of the biggest ongoing challenges for companies in this space, including The Peptique.
Because of that, you may continue to see changes in product naming, listings, or how certain products are presented. These adjustments are often necessary just to keep things operational behind the scenes.
My goal has always been to adapt and move with the landscape so we can keep research peptides available for as long as possible. Sometimes that means making strategic shifts that may look confusing from the outside but are necessary for sustainability.
You may have also noticed that I’ve been a little quieter on social media lately. That has been intentional. The Peptique is still a relatively small company, and in many ways my hope is that staying smaller and somewhat under the radar helps us continue operating without drawing unnecessary attention.
Please know that I am constantly monitoring what’s happening in the space and doing everything I can to navigate these changes responsibly and thoughtfully.
I’ll continue to keep this community updated as things evolve.
Thank you all for being here and for being part of this group!